5min chapter

Barbell Medicine Podcast cover image

Episode #209: Obesity Medications

Barbell Medicine Podcast

CHAPTER

Glucagon Like Peptide One

Liraglutide was initially approved for type two diabetes in 2010 because GLP one increases insulin release from the pancreas to help control blood sugar. It also acts at the level of the brain because there are GLP one receptors there, specifically in the hypothalamus. Subsequently, liraglUTide was approved by the FDA for treating obesity and it's about 5% greater than placebo with respect to weight loss outcomes.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode